Baldwin Wealth Partners LLC MA Sells 56,909 Shares of Danaher Corporation $DHR

Key Points

• Baldwin Wealth Partners cut its Danaher stake by 86.3% in the third quarter, selling 56,909 shares and retaining 9,026 shares valued at approximately $2 million.
• Danaher reported quarterly earnings of $1.94 per share and revenue of $6.26 billion, exceeding analyst expectations; revenue increased 5.5% year over year.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $234.55, compared with the stock’s reported price of $221.26.

Baldwin Wealth Partners LLC MA lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 86.3% in the third quarter, according to its most recent filing with the SEC. The firm owned 9,026 shares of the conglomerate's stock after selling 56,909 shares during the period. Baldwin Wealth Partners LLC MA's holdings in Danaher were worth $2,000,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in DHR. Veery Capital LLC lifted its stake in Danaher by 3.1% in the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate's stock valued at $350,000 after buying an additional 48 shares during the period. Studio Investment Management LLC increased its stake in shares of Danaher by 3.3% in the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate's stock valued at $302,000 after acquiring an additional 51 shares during the last quarter. JDH Wealth Management LLC increased its stake in shares of Danaher by 4.5% in the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate's stock valued at $240,000 after acquiring an additional 55 shares during the last quarter. OLD Second National Bank of Aurora raised its position in shares of Danaher by 0.5% in the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate's stock valued at $2,297,000 after acquiring an additional 57 shares during the period. Finally, Adelphi Trust Co raised its position in shares of Danaher by 2.5% in the 3rd quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate's stock valued at $524,000 after acquiring an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Performance

DHR opened at $221.26 on Tuesday. The company has a market capitalization of $155.54 billion, a price-to-earnings ratio of 39.30, a P/E/G ratio of 2.74 and a beta of 0.76. The business's 50-day moving average price is $211.85 and its two-hundred day moving average price is $194.88. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. Danaher's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. Equities analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's dividend payout ratio (DPR) is currently 28.42%.

Analyst Ratings Changes

DHR has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research report on Saturday. Morgan Stanley reiterated an "overweight" rating and set a $240.00 price objective on shares of Danaher in a report on Monday. Evercore reissued an "outperform" rating and set a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Finally, TD Cowen dropped their target price on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $234.55.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.